![Gordon Naylor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gordon Naylor
Directeur Général chez
CSL LIMITED
Fortune : 3 M $ au 31/05/2026
Profil
Gordon Naylor is Chief Executive Officer, MD & Director at CSL Ltd. since 2026.
Mr. Naylor is Independent Non-Executive Director at Orica Ltd. since 2022.
Mr. Naylor is Director at Seqirus Holdings UK Ltd. since 2015.
Mr. Naylor is Senior Vice President & General Manager at CSL Plasma, Inc. Former roles include Non-Executive Chairman at Medical Developments International Ltd. from 2020 to 2025, Chief Financial Officer at CSL Ltd. from 2010 to 2016, EVP-Plasma, Supply Chain & Information Systems at CSL Behring LLC, and President at Seqirus UK Ltd. from 2015 to 2019.
Education includes an MBA from Melbourne Business School and an undergraduate degree from the University of Melbourne.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CSL LIMITED 0,01 % | 26/05/2026 | 40 819 ( 0,01 % ) | 3 M $ | 31/05/2026 |
| 15/08/2025 | 1 045 113 ( 0,93 % ) | 289 507 $ | 31/05/2026 | |
| 30/09/2025 | 16 394 ( 0 % ) | 269 999 $ | 31/05/2026 |
Postes actifs de Gordon Naylor
| Sociétés | Poste | Début |
|---|---|---|
| ORICA LIMITED | Directeur/Membre du Conseil | 01/04/2022 |
| CSL LIMITED | Directeur Général | 11/02/2026 |
CSL Plasma, Inc.
 CSL Plasma, Inc. Medical/Nursing ServicesHealth Services Collects blood donations | Corporate Officer/Principal | - |
Seqirus Holdings UK Ltd.
 Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 29/05/2015 |
Anciens postes connus de Gordon Naylor
| Sociétés | Poste | Fin |
|---|---|---|
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Président | 01/12/2025 |
Seqirus UK Ltd.
 Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and delivers therapies for people living with conditions in the immunology, hematology, cardiovascular, metabolic, respiratory & transplant therapeutic areas | President | 01/06/2019 |
| CSL LIMITED | Directeur Financier/CFO | 02/01/2016 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Directeur Financier/CFO | - |
Formation de Gordon Naylor
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Medical Developments International Ltd.
 Medical Developments International Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical drugs & medical equipment | Health Technology |
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orica Ltd.
 Orica Ltd. Industrial SpecialtiesProcess Industries Manufactures and distributes commercial blasting systems & mining and tunneling support systems to the mining and infrastructure markets | Process Industries |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services Collects blood donations | Health Services |
Seqirus UK Ltd.
Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and delivers therapies for people living with conditions in the immunology, hematology, cardiovascular, metabolic, respiratory & transplant therapeutic areas | Health Technology |
Seqirus Holdings UK Ltd.
Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
